Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 169

1.

Activation and Proliferation of PD-1+ Kidney Double-Negative T Cells Is Dependent on Nonclassical MHC Proteins and IL-2.

Sadasivam M, Noel S, Lee SA, Gong J, Allaf ME, Pierorazio P, Rabb H, Hamad ARA.

J Am Soc Nephrol. 2019 Jan 8. pii: ASN.2018080815. doi: 10.1681/ASN.2018080815. [Epub ahead of print]

PMID:
30622155
2.

Obscenity, Michael Jordan, and Measuring Outcomes: Explaining and Improving the Quality of Kidney Cancer Care.

Pierorazio P, Eggener S.

Eur Urol. 2018 Dec 18. pii: S0302-2838(18)31022-4. doi: 10.1016/j.eururo.2018.12.017. [Epub ahead of print] No abstract available.

PMID:
30578120
3.

Use of delayed intervention for small renal masses initially managed with active surveillance.

Gupta M, Alam R, Patel HD, Semerjian A, Gorin MA, Johnson MH, Chang P, Wagner AA, McKiernan JM, Allaf ME, Pierorazio PM.

Urol Oncol. 2019 Jan;37(1):18-25. doi: 10.1016/j.urolonc.2018.10.001. Epub 2018 Nov 13.

PMID:
30446459
4.

Molecular Imaging for Evaluation of Viable Testicular Cancer Nodal Metastases.

Joice GA, Rowe SP, Gorin MA, Pierorazio PM.

Curr Urol Rep. 2018 Nov 9;19(12):110. doi: 10.1007/s11934-018-0863-3. Review.

PMID:
30413968
5.

Patient Decision-making and Predictors of Genital Satisfaction Associated With Testicular Prostheses After Radical Orchiectomy: A Questionnaire-based Study of Men With Germ Cell Tumors of the Testicle.

Nichols PE, Harris KT, Brant A, Manka MG, Haney N, Johnson MH, Herati A, Allaf ME, Pierorazio PM.

Urology. 2018 Oct 28. pii: S0090-4295(18)31053-7. doi: 10.1016/j.urology.2018.09.021. [Epub ahead of print]

PMID:
30381246
6.

Inconsistent Detection of Sites of Metastatic Non-Clear Cell Renal Cell Carcinoma with PSMA-Targeted [18F]DCFPyL PET/CT.

Yin Y, Campbell SP, Markowski MC, Pierorazio PM, Pomper MG, Allaf ME, Rowe SP, Gorin MA.

Mol Imaging Biol. 2018 Sep 14. doi: 10.1007/s11307-018-1271-2. [Epub ahead of print]

PMID:
30218388
7.

Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer.

Johnson SC, Smith ZL, Nottingham C, Schwen ZR, Thomas S, Fishman EK, Lee NJ, Pierorazio PM, Eggener SE.

Urology. 2019 Jan;123:186-190. doi: 10.1016/j.urology.2018.08.028. Epub 2018 Sep 1.

PMID:
30179635
8.

Spontaneous Regression of a Low-Grade Renal Cell Carcinoma With Oncocytic Features After Renal Mass Biopsy.

Srivastava A, Meyer AR, Pierorazio PM, Rowe SP, Allaf ME, Gorin MA.

Clin Genitourin Cancer. 2018 Dec;16(6):e1083-e1085. doi: 10.1016/j.clgc.2018.07.012. Epub 2018 Jul 21. No abstract available.

PMID:
30097254
9.

Comparative effectiveness of management options for patients with small renal masses: a prospective cohort study.

Alam R, Patel HD, Osumah T, Srivastava A, Gorin MA, Johnson MH, Trock BJ, Chang P, Wagner AA, McKiernan JM, Allaf ME, Pierorazio PM.

BJU Int. 2019 Jan;123(1):42-50. doi: 10.1111/bju.14490. Epub 2018 Aug 9.

PMID:
30019484
10.

Hospitalisation and readmission costs after radical cystectomy in a nationally representative sample: does urinary reconstruction matter?

Joice GA, Chappidi MR, Patel HD, Kates M, Sopko NA, Stimson CJ, Pierorazio PM, Bivalacqua TJ.

BJU Int. 2018 Dec;122(6):1016-1024. doi: 10.1111/bju.14448. Epub 2018 Jul 26.

PMID:
29897156
11.

Characterization of kidney CD45intCD11bintF4/80+MHCII+CX3CR1+Ly6C- "intermediate mononuclear phagocytic cells".

Lee SA, Noel S, Sadasivam M, Allaf ME, Pierorazio PM, Hamad ARA, Rabb H.

PLoS One. 2018 Jun 1;13(6):e0198608. doi: 10.1371/journal.pone.0198608. eCollection 2018. Erratum in: PLoS One. 2018 Jun 27;13(6):e0200056.

12.

A Review of Outcomes and Technique for the Robotic-Assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer.

Schwen ZR, Gupta M, Pierorazio PM.

Adv Urol. 2018 May 3;2018:2146080. doi: 10.1155/2018/2146080. eCollection 2018. Review.

13.

Characterization of the Macrophage Infiltrate in a Case of Xanthogranulomatous Pyelonephritis.

Zarif JC, Chalfin HJ, Pierorazio PM, Gorin MA.

J Clin Urol. 2018 May;11(3):226-228. doi: 10.1177/2051415817716014. Epub 2017 Jun 16. No abstract available.

14.

Active Surveillance of Small Renal Masses: A Safe Management Strategy for Select Patients.

Gupta M, Patel HD, Pierorazio PM.

Eur Urol. 2018 Aug;74(2):165-166. doi: 10.1016/j.eururo.2018.04.011. Epub 2018 Apr 21. No abstract available.

PMID:
29685642
15.

Non-risk-adapted Surveillance for Stage I Testicular Cancer: Critical Review and Summary.

Pierorazio PM, Albers P, Black PC, Tandstad T, Heidenreich A, Nicolai N, Nichols C.

Eur Urol. 2018 Jun;73(6):899-907. doi: 10.1016/j.eururo.2017.12.030. Epub 2018 Jan 12. Review.

PMID:
29338978
16.

Comparison of Pathological Stage in Patients Treated with and without Neoadjuvant Chemotherapy for High Risk Upper Tract Urothelial Carcinoma.

Liao RS, Gupta M, Schwen ZR, Patel HD, Kates M, Johnson MH, Hahn NM, McConkey D, Bivalacqua TJ, Pierorazio PM.

J Urol. 2018 Jul;200(1):68-73. doi: 10.1016/j.juro.2017.12.054. Epub 2018 Jan 4.

PMID:
29307680
17.

Editorial Comment.

Gupta M, Pierorazio PM.

Urology. 2018 Feb;112:110-111. doi: 10.1016/j.urology.2017.08.060. Epub 2017 Dec 6. No abstract available.

PMID:
29198422
18.

Margin Assessment in Renal Surgery Using a Handheld Optical Coherence Tomography Probe.

Ludwig WW, Wobker SE, Ball MW, Zysk AM, Yemul KS, Pierorazio PM, Gorin MA, Allaf ME.

Urology. 2018 Mar;113:241-245. doi: 10.1016/j.urology.2017.11.029. Epub 2017 Nov 28.

PMID:
29196067
19.

Oncological Outcomes of Sequential Intravesical Gemcitabine and Docetaxel in Patients with Non-Muscle Invasive Bladder Cancer.

Milbar N, Kates M, Chappidi MR, Pederzoli F, Yoshida T, Sankin A, Pierorazio PM, Schoenberg MP, Bivalacqua TJ.

Bladder Cancer. 2017 Oct 27;3(4):293-303. doi: 10.3233/BLC-170126.

20.

Selecting Patients with Small Renal Masses for Active Surveillance.

Johnson MH, Allaf ME, Pierorazio PM.

Anticancer Agents Med Chem. 2018;18(7):931-939. doi: 10.2174/1871520617666171113152225.

PMID:
29141556
21.

Hospital Charges and Length of Stay Following Radical Cystectomy in the Enhanced Recovery After Surgery Era.

Semerjian A, Milbar N, Kates M, Gorin MA, Patel HD, Chalfin HJ, Frank SM, Wu CL, Yang WW, Hobson D, Robertson L, Wick E, Schoenberg MP, Pierorazio PM, Johnson MH, Stimson CJ, Bivalacqua TJ.

Urology. 2018 Jan;111:86-91. doi: 10.1016/j.urology.2017.09.010. Epub 2017 Oct 13.

PMID:
29032237
22.

Retroperitoneal lymph node dissection for testicular seminomas: population-based practice and survival outcomes.

Patel HD, Joice GA, Schwen ZR, Semerjian A, Alam R, Srivastava A, Allaf ME, Pierorazio PM.

World J Urol. 2018 Jan;36(1):73-78. doi: 10.1007/s00345-017-2099-0. Epub 2017 Oct 12.

PMID:
29026972
23.

Multiple growth periods predict unfavourable pathology in patients with small renal masses.

Jang A, Patel HD, Riffon M, Gorin MA, Semerjian A, Johnson MH, Allaf ME, Pierorazio PM.

BJU Int. 2018 May;121(5):732-736. doi: 10.1111/bju.14051. Epub 2017 Nov 1.

PMID:
28990323
24.

Correlation of 99mTc-sestamibi uptake in renal masses with mitochondrial content and multi-drug resistance pump expression.

Rowe SP, Gorin MA, Solnes LB, Ball MW, Choudhary A, Pierorazio PM, Epstein JI, Javadi MS, Allaf ME, Baras AS.

EJNMMI Res. 2017 Oct 2;7(1):80. doi: 10.1186/s13550-017-0329-5.

25.

Incidence of T3a up-staging and survival after partial nephrectomy: Size-stratified rates and implications for prognosis.

Srivastava A, Patel HD, Joice GA, Semerjian A, Gorin MA, Johnson MH, Allaf ME, Pierorazio PM.

Urol Oncol. 2018 Jan;36(1):12.e7-12.e13. doi: 10.1016/j.urolonc.2017.09.005. Epub 2017 Sep 29.

PMID:
28970053
26.

Growth Kinetics of Small Renal Masses on Active Surveillance: Variability and Results from the DISSRM Registry.

Uzosike AC, Patel HD, Alam R, Schwen ZR, Gupta M, Gorin MA, Johnson MH, Gausepohl H, Riffon MF, Trock BJ, Chang P, Wagner AA, McKiernan JM, Allaf ME, Pierorazio PM.

J Urol. 2018 Mar;199(3):641-648. doi: 10.1016/j.juro.2017.09.087. Epub 2017 Sep 23.

PMID:
28951284
27.

Frontiers in robot-assisted retroperitoneal oncological surgery.

Ludwig WW, Gorin MA, Pierorazio PM, Allaf ME.

Nat Rev Urol. 2017 Dec;14(12):731-741. doi: 10.1038/nrurol.2017.149. Epub 2017 Sep 12. Review.

PMID:
28895564
28.

High dose-rate Intra-Operative Radiation Therapy During High Risk Genitourinary Surgery: Initial Observations and a Proposal for its Study in Bladder Cancer.

Kates M, Chappidi MR, Brant A, Milbar N, Sopko NA, Meyer C, Terezakis SA, Herman JM, Efron JE, Safar B, Tran PT, Ahuja N, Pierorazio PM, Bivalacqua TJ.

Bladder Cancer. 2017 Jul 27;3(3):191-199. doi: 10.3233/BLC-170104.

29.

Small Renal Mass-To Biopsy or Not? The Role of Biopsy in Evaluation.

Patel HD, Pierorazio PM.

Eur Urol Focus. 2016 Jun;2(2):154-155. doi: 10.1016/j.euf.2015.09.008. Epub 2015 Oct 23. No abstract available.

PMID:
28723530
30.

Radiotherapy for stage I and II testicular seminomas: Secondary malignancies and survival.

Patel HD, Srivastava A, Alam R, Joice GA, Schwen ZR, Semerjian A, Allaf ME, Pierorazio PM.

Urol Oncol. 2017 Oct;35(10):606.e1-606.e7. doi: 10.1016/j.urolonc.2017.06.051. Epub 2017 Jul 13.

PMID:
28712791
31.

Kidney Cancer, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology.

Motzer RJ, Jonasch E, Agarwal N, Bhayani S, Bro WP, Chang SS, Choueiri TK, Costello BA, Derweesh IH, Fishman M, Gallagher TH, Gore JL, Hancock SL, Harrison MR, Kim W, Kyriakopoulos C, LaGrange C, Lam ET, Lau C, Michaelson MD, Olencki T, Pierorazio PM, Plimack ER, Redman BG, Shuch B, Somer B, Sonpavde G, Sosman J, Dwyer M, Kumar R.

J Natl Compr Canc Netw. 2017 Jun;15(6):804-834. doi: 10.6004/jnccn.2017.0100.

PMID:
28596261
32.

Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.

Patel HD, Pierorazio PM, Johnson MH, Sharma R, Iyoha E, Allaf ME, Bass EB, Sozio SM.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1057-1069. doi: 10.2215/CJN.11941116. Epub 2017 May 8. Review.

33.

Renal Mass and Localized Renal Cancer: AUA Guideline.

Campbell S, Uzzo RG, Allaf ME, Bass EB, Cadeddu JA, Chang A, Clark PE, Davis BJ, Derweesh IH, Giambarresi L, Gervais DA, Hu SL, Lane BR, Leibovich BC, Pierorazio PM.

J Urol. 2017 Sep;198(3):520-529. doi: 10.1016/j.juro.2017.04.100. Epub 2017 May 4.

PMID:
28479239
34.

Erectile Dysfunction Treatment Following Radical Cystoprostatectomy: Analysis of a Nationwide Insurance Claims Database.

Chappidi MR, Kates M, Sopko NA, Joice GA, Tosoian JJ, Pierorazio PM, Bivalacqua TJ.

J Sex Med. 2017 Jun;14(6):810-817. doi: 10.1016/j.jsxm.2017.04.002. Epub 2017 Apr 29.

PMID:
28460994
35.

Evaluation of gender-based disparities in time from initial haematuria presentation to upper tract urothelial carcinoma diagnosis: analysis of a nationwide insurance claims database.

Chappidi MR, Kates M, Tosoian JJ, Johnson MH, Hahn NM, Bivalacqua TJ, Pierorazio PM.

BJU Int. 2017 Sep;120(3):377-386. doi: 10.1111/bju.13878. Epub 2017 May 17.

36.

Defining the Role of Intraoperative Transesophageal Echocardiography During Radical Nephrectomy With Inferior Vena Cava Tumor Thrombectomy for Renal Cell Carcinoma.

Kostibas MP, Arora V, Gorin MA, Ball MW, Pierorazio PM, Allaf ME, Nyhan D, Brady MB.

Urology. 2017 Sep;107:161-165. doi: 10.1016/j.urology.2017.03.008. Epub 2017 Mar 30.

PMID:
28366705
37.

Postoperative complications following intraoperative radiotherapy in abdominopelvic malignancy: A single institution analysis of 113 consecutive patients.

Abdelfatah E, Page A, Sacks J, Pierorazio P, Bivalacqua T, Efron J, Terezakis S, Gearhart S, Fang S, Safar B, Pawlik TM, Armour E, Hacker-Prietz A, Herman J, Ahuja N.

J Surg Oncol. 2017 Jun;115(7):883-890. doi: 10.1002/jso.24597. Epub 2017 Mar 2.

38.

Reply by the Authors.

Ball MW, Pierorazio PM.

Urology. 2017 May;103:274. doi: 10.1016/j.urology.2017.02.024. Epub 2017 Feb 22. No abstract available.

PMID:
28237529
39.

Active surveillance is superior to radical nephrectomy and equivalent to partial nephrectomy for preserving renal function in patients with small renal masses: Results from the DISSRM registry.

Danzig MR, Ghandour RA, Chang P, Wagner AA, Pierorazio PM, Allaf ME, McKiernan JM.

Urol Oncol. 2017 Mar;35(3):116. doi: 10.1016/j.urolonc.2016.05.011.

PMID:
28215846
40.

Mildly elevated serum alpha-fetoprotein (AFP) among patients with testicular cancer may not be associated with residual cancer or need for treatment.

Wymer KM, Daneshmand S, Pierorazio PM, Pearce SM, Harris KT, Eggener SE.

Ann Oncol. 2017 Apr 1;28(4):899-902. doi: 10.1093/annonc/mdx012. No abstract available.

PMID:
28137740
41.

Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses.

Sheikhbahaei S, Jones CS, Porter KK, Rowe SP, Gorin MA, Baras AS, Pierorazio PM, Ball MW, Higuchi T, Johnson PT, Solnes LB, Epstein JI, Allaf ME, Javadi MS.

Clin Nucl Med. 2017 Apr;42(4):e188-e193. doi: 10.1097/RLU.0000000000001534.

PMID:
28114223
42.

Assessing Cancer Progression and Stable Disease After Neoadjuvant Chemotherapy for Organ-confined Muscle-invasive Bladder Cancer.

Chappidi MR, Kates M, Brant A, Baras AS, Netto GJ, Pierorazio PM, Hahn NM, Bivalacqua TJ.

Urology. 2017 Apr;102:148-158. doi: 10.1016/j.urology.2016.10.064. Epub 2017 Jan 16.

43.

Mortality trends and the impact of lymphadenectomy on survival for renal cell carcinoma patients with distant metastasis.

Patel HD, Gorin MA, Gupta N, Kates M, Johnson MH, Pierorazio PM, Allaf ME.

Can Urol Assoc J. 2016 Nov-Dec;10(11-12):389-395. doi: 10.5489/cuaj.1999.

44.

Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.

Patel HD, Druskin SC, Rowe SP, Pierorazio PM, Gorin MA, Allaf ME.

BJU Int. 2017 May;119(5):661-666. doi: 10.1111/bju.13763. Epub 2017 Feb 27. Review.

45.

Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes.

An JY, Ball MW, Gorin MA, Hong JJ, Johnson MH, Pavlovich CP, Allaf ME, Pierorazio PM.

Urology. 2017 Feb;100:151-157. doi: 10.1016/j.urology.2016.10.047. Epub 2016 Nov 23.

46.

Call Schedule and Sleep Patterns of Urology Residents Following the 2011 ACGME Reforms.

Ko JS, Readal N, Ball MW, Han M, Pierorazio PM.

Urol Pract. 2016 Mar;3(2):147-152.

47.

Kidney cancer: Undertreatment of small renal masses by overuse of biopsy.

Patel HD, Pierorazio PM.

Nat Rev Urol. 2016 Dec;13(12):701-703. doi: 10.1038/nrurol.2016.213. Epub 2016 Nov 2. Review. No abstract available.

PMID:
27804990
48.

Distinguishing malignant and benign renal masses with composite models and nomograms: A systematic review and meta-analysis of clinically localized renal masses suspicious for malignancy.

Pierorazio PM, Patel HD, Johnson MH, Sozio SM, Sharma R, Iyoha E, Bass EB, Allaf ME.

Cancer. 2016 Nov 15;122(21):3267-3276. doi: 10.1002/cncr.30268. Epub 2016 Aug 10. Review.

49.

A Prospective, Comparative Study of Quality of Life among Patients with Small Renal Masses Choosing Active Surveillance and Primary Intervention.

Patel HD, Riffon MF, Joice GA, Johnson MH, Chang P, Wagner AA, McKiernan JM, Trock BJ, Allaf ME, Pierorazio PM.

J Urol. 2016 Nov;196(5):1356-1362. doi: 10.1016/j.juro.2016.04.073. Epub 2016 Apr 30.

PMID:
27140071
50.

Supplemental Content

Loading ...
Support Center